Pawel Mroz
Pawel Mroz
Patvirtintas el. paštas
Photodynamic therapy of cancer: an update
P Agostinis, K Berg, KA Cengel, TH Foster, AW Girotti, SO Gollnick, ...
CA: a cancer journal for clinicians 61 (4), 250-281, 2011
Photodynamic therapy and anti-tumour immunity
AP Castano, P Mroz, MR Hamblin
Nature Reviews Cancer 6 (7), 535-545, 2006
Cell death pathways in photodynamic therapy of cancer
P Mroz, A Yaroslavsky, GB Kharkwal, MR Hamblin
Cancers 3 (2), 2516-2539, 2011
Photodynamic therapy with fullerenes
P Mroz, GP Tegos, H Gali, T Wharton, T Sarna, MR Hamblin
Photochemical & Photobiological Sciences 6 (11), 1139-1149, 2007
Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism
P Mroz, A Pawlak, M Satti, H Lee, T Wharton, H Gali, T Sarna, ...
Free Radical Biology and Medicine 43 (5), 711-719, 2007
Stimulation of anti-tumor immunity by photodynamic therapy
P Mroz, JT Hashmi, YY Huang, N Lange, MR Hamblin
Expert review of clinical immunology 7 (1), 75-91, 2011
Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model
AP Castano, P Mroz, MX Wu, MR Hamblin
Proceedings of the National Academy of Sciences 105 (14), 5495-5500, 2008
Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin (e6) for broad-spectrum antimicrobial photoinactivation
GP Tegos, M Anbe, C Yang, TN Demidova, M Satti, P Mroz, S Janjua, ...
Antimicrobial agents and chemotherapy 50 (4), 1402-1410, 2006
Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells
A Jalili, M Makowski, T Switaj, D Nowis, GM Wilczynski, E Wilczek, ...
Clinical Cancer Research 10 (13), 4498-4508, 2004
Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response
P Mroz, A Szokalska, MX Wu, MR Hamblin
PloS one 5 (12), e15194, 2010
Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol: A superoxide dismutase inhibitor
JG Ğb, D Nowis, M Skrzycki, H Czeczot, A Barańczyk-Kuźma, ...
Journal of Biological Chemistry 278 (1), 407-414, 2003
Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers
L Huang, YY Huang, P Mroz, GP Tegos, T Zhiyentayev, SK Sharma, Z Lu, ...
Antimicrobial agents and chemotherapy 54 (9), 3834-3841, 2010
Design features for optimization of tetrapyrrole macrocycles as antimicrobial and anticancer photosensitizers
A Martinez De Pinillos Bayona, P Mroz, C Thunshelle, MR Hamblin
Chemical biology & drug design 89 (2), 192-206, 2017
Photodynamic therapy for cancer and for infections: what is the difference?
SK Sharma, P Mroz, T Dai, YY Huang, TGS Denis, MR Hamblin
Israel journal of chemistry 52 (8‐9), 691-705, 2012
Imidazole metalloporphyrins as photosensitizers for photodynamic therapy: role of molecular charge, central metal and hydroxyl radical production
P Mroz, J Bhaumik, DK Dogutan, Z Aly, Z Kamal, L Khalid, HL Kee, ...
Cancer letters 282 (1), 63-76, 2009
Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy
P Mroz, YY Huang, A Szokalska, T Zhiyentayev, S Janjua, AP Nifli, ...
The FASEB journal 24 (9), 3160, 2010
Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response
A Szokalska, M Makowski, D Nowis, GM Wilczynski, M Kujawa, C Wójcik, ...
Cancer research 69 (10), 4235-4243, 2009
In vitro photodynamic therapy and quantitative structure− activity relationship studies with stable synthetic near-infrared-absorbing bacteriochlorin photosensitizers
YY Huang, P Mroz, T Zhiyentayev, SK Sharma, T Balasubramanian, ...
Journal of medicinal chemistry 53 (10), 4018-4027, 2010
Photophysical characterization of imidazolium-substituted Pd (II), In (III), and Zn (II) porphyrins as photosensitizers for photodynamic therapy
HL Kee, J Bhaumik, JR Diers, P Mroz, MR Hamblin, DF Bocian, ...
Journal of Photochemistry and Photobiology A: Chemistry 200 (2-3), 346-355, 2008
EphA2 is a critical oncogene in melanoma
D Udayakumar, G Zhang, Z Ji, CN Njauw, P Mroz, H Tsao
Oncogene 30 (50), 4921-4929, 2011
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20